For instance, treating patients with wide-type EGFR lung cancer with cisplatin revealed that TKIs produced neither a synergistic nor an enhancing effect on platinum-based chemotherapy, with some evidence pointing to a possible antagonistic effect [54]. This evidence concerns the gene EGFR and lung cancer.